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Antibiotic resistance is a growing concern in medical and veterinary settings.  
Resistance can be worsened by misuse and overuse of antibiotics.  Such situations can 
give rise to highly resistant organisms.  Ciprofloxacin, a synthetic, broad-spectrum 
antibiotic used to treat gram-positive and gram-negative infections in humans, has similar 
chemical structure to enrofloxacin, which is used to treat animals.  Cross-resistance might 
arise because of that similarity.  This research describes the dispersal and prevalence of 
bacteria that exhibit ciprofloxacin resistance in relation to feedlots in the central Great 
Plains region.  Six times in 2013, six feedlots were sampled for airborne bacterial 
communities at, upwind of, and downwind of the feedlot.  The samples were grown on 
exposed Mueller Hinton agar plates infused with a clinical dose of ciprofloxacin.  After 
incubation, bacterial colonies were counted, indicating the prevalence of resistant 
bacteria.  Other variables were measured and analyzed, including wind speed, air 
temperature, and relative humidity.  Colony prevalence was higher on the feedlots than at 
any of the locations upwind and downwind of the lots.  Wind speed, relative humidity, 
and distance from the feedlot significantly influenced the number of colonies that were 
detected.  Some colonies from among the samples were isolated, gram-stained, tested for 
minimum inhibitory concentrations of ciprofloxacin, and sequenced for species 
identification.  21 bacterial isolates represented eight species in four genera: 
Enteroccocus, Cellulomonas, Arthrobacter, and Microbacterium.  Though species 
richness in this study was somewhat low, the bacterial isolates showed high levels of 
ciprofloxacin resistance.  Because the prevalence of ciprofloxacin-resistant bacterial 




suggested that the feedlots have a relatively small effect on the dispersal of ciprofloxacin-
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Antimicrobials, a bulwark of 20th century medicine, are losing their effectiveness 
due to overuse and misuse, and infections that were once easily treated threaten human 
lives again.  The era of antibiotics started with the use of arsenic compounds like 
Salvarsan, sulfa drugs like Prontosil, and the first beta-lactam, penicillin.  The most 
productive period of antibiotic development, between the 1950s and the mid 1970s, 
included the development of additional classes of drugs and new derivatives of existing 
antibiotic drugs (1, 2).  However, the development of drugs with new mechanisms of 
action has slowed in the past 30 years.  Low profit margins, short periods of applicability, 
scientific research hurdles, and increased demands for prudent and regulated use have 
contributed to this slowed development (3). 
Antibiotics can be classified based on their mechanisms of action.  Drugs that 
interfere with bacterial cell wall synthesis include the beta-lactams (penicillins, 
cephalosporins, carbapenems, etc.) and the glycopeptides (vancomycin and teicoplanin), 
which inhibit cross-linking of peptidoglycan layers of the cell wall (4).   Drugs that 
inhibit protein synthesis do so by multiple mechanisms.  Tetracyclines (tetracycline and 
doxycycline) block attachment of the aminoacyl-transfer RNA complex to the 30s 
ribosomal subunit.  Aminoglycosides (gentamicin, streptomycin, etc.) bind directly or 
indirectly to ribosomes.  Chloramphenicol hinders peptide chain-lengthening bond 
formation by binding to the 50s ribosomal subunit, and macrolides (erythromycin, 
azithromycin, and clindamycin), the synergistic streptogramins (quinupristin-
dalfopristin), and the newer oxazolidinones (the synthetic drug linezolid) also all bind to 
the 50s subunit (4).  Drugs that disrupt nucleic acid synthesis in bacteria by interfering 
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with synthesis of folic acid include the sulfonamides and trimethoprim-sulfamethoxazole 
(4).  
 The quinolone class is a class of broad-spectrum nucleic acid synthesis inhibitors.  
Members of this class contain a 4-quinolone nucleus and a carboxylate substituent at the 
C3 position (5).  The first-generation of the quinolone class includes nalidixic acid (1,8-
naphthyridine), a completely synthetic compound (6), oxolinic acid and pipemidic acid.  
Second-generation quinolone drugs such as ciprofloxacin, which have increased activity 
against gram-negatives and some intracellular bacteria (7), have a fluorine atom added to 
the C6 position on the quinolone nucleus, and are referred to as fluoroquinolones (5) (Fig 
1, Fig 2).  Third-generation and later quinolones have increased activity against gram-
positive and anaerobic bacteria, contributing to the broad activity of this class of drugs.  
 The novel mechanism of action of the fluoroquinolones has made them an 
important class of antibiotics.  Fluoroquinolones interfere with DNA synthesis by 
targeting bacterial enzymes.  The target of fluoroquinolone action in gram-negative 
bacteria is DNA gyrase, and in gram-positive bacteria is DNA topoisomerase IV (8, 9), 
but the drugs target both enzymes to some degree.  DNA gyrase is composed of 2 GyrA 
subunits and 2 GyrB subunits that produce negative supercoiling of DNA, which initiates 
DNA replication, and also alleviates positive supercoiling in front of the replication fork 
(8).  DNA topoisomerase IV also has four subunits, 2 ParC and 2 ParE subunits, which 
are analogous to the subunits of DNA gyrase.  Topoisomerase IV facilitates the 
separation of interlinked daughter DNA strands so they can be segregated into daughter 
cells at the end of replication (8, 9).  The fluoroquinolone drugs bind to these enzymes 
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and form large drug-enzyme-DNA complexes, which bind irreversibly to the DNA 
molecules and block activity near the replication fork (7, 8). 
 Despite an arsenal of antibiotic drugs with a variety of targets and mechanisms of 
activity, resistance to antibiotics has been a problem since their beginning.  Antibiotic 
resistance can be a property intrinsic to the bacterial cell or a property that the organism 
acquires through genetic mutations, gene transfer from the environment, or with plasmids 
from neighboring cells.  Sub-therapeutic levels of antibiotic treatment, levels low enough 
that some organisms survive, promote resistance (10, 11, 12).  The bacterial cells that are 
not eliminated and can grow in the presence of the drug are able to use the resources and 
the space vacated by those cells that did not survive.  Antibiotic resistance can be 
grouped into a few major mechanisms: minimizing the concentration of the drug within 
the cell by restricting the inward flow of the drug or actively pumping the drug out; 
rendering the antibiotic useless by altering its structure; or lowering the affinity of the 
drug for the target by altering the structure of the drug’s target (10).   
Genes encoding for antibiotic resistance have been observed in potentially 
pathogenic bacteria.  A number of clinically relevant species exhibit widespread 
resistance, and the high selective pressure of hospital environments might contribute to 
the persistence of endemic, multi-drug resistant bacterial strains.  For example, patients in 
a Swedish hospital carried multi-drug resistant coagulase-negative Staphylocccus (CNS) 
isolates (primarily S. epidermidis) that were identical to CNS isolates from patients 
treated a year prior (13).  Multi-drug resistant Salmonella species have been isolated from 
birds and pens on both conventional, where broilers are reared in large barns and fed 
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feed-grade antibiotics, and pasture, where broilers are reared outdoors in movable pens, 
poultry farms in the United States.  However, the pasture farms showed a lower 
prevalence of Salmonella resistance than did conventional farms (11).  Escherichia coli is 
a reservoir for antibiotic-resistance genes, and it is commonly found in the intestinal 
tracts of humans and animals.  Nearly 90% of the E. coli isolates obtained from the stool 
of children, cow dung, or drinking water in two regions of India were resistant to at least 
one of ten tested antibiotics, including isolates from sources that had little history of 
antibiotic treatment (14). 
Resistant bacteria have been detected in diverse environments.  In northern 
Colorado, drinking water and recycled wastewater were found to contain detectable 
levels of two different genes for resistance to tetracycline (15).  In communities with poor 
sanitation, resistance could be spread to the environment.  The detection of antibiotic-
resistance genes, and in some cases, multi-drug resistance, has been observed in the 
environment or organisms that have no known exposure to antibiotics.  A study in 
England found resistance to seven antibiotics in enteric commensal Enterobacteriaceae 
isolated from bank vole (Clethrionomys glareolus) and wood mouse (Apodemus 
sylvaticus) populations, suggesting that antibiotic resistance might be widespread in wild 
populations (16). 
The presence of drugs in the environment can be attributed to the nature of the 
drugs themselves.  Antibiotic drugs can enter sewage treatment plants after being 
excreted into wastewater or after drugs are discarded (12).  If drugs are not completely 
mineralized at the sewage plants, they might enter the surface water or sludge.  Drugs 
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administered to animals that are not fully metabolized might be found in manure or 
surface soil.  Sludge and manure are used as fertilizers in agriculture.  Antibiotics used in 
fish farming are administered into the water and can enter soil and sediment layers 
without undergoing purification or being metabolized (12).  For new pharmaceuticals, an 
environmental risk assessment (ERA) is conducted to estimate the risk of its use.  
However, since there are no regulations requiring that the effects of current 
pharmaceuticals be estimated, little is known about the effects of older drugs (17).  
Studies of ciprofloxacin have suggested that it tends to adsorb onto sludge, sediments, 
and soil particles.  As ciprofloxacin is not readily biodegradable, this leads to 
accumulation in the environment (12, 17, 18, 19).  Accumulation and lack of 
biodegradation has been noted more frequently with fully- or semi-synthetic drugs than 
with naturally derived antibiotics (12).  Exposure to a partially metabolized molecule that 
is nearly identical to an original drug, especially at sub-therapeutic levels, has the 
potential to encourage resistance in organisms.  
 Mechanisms of resistance to fluoroqinolones include alteration of the target 
enzymes (DNA gyrase and DNA topoisomerase IV) and reduced concentration of the 
drug inside the target cell (8, 9).  Point mutations in the quinolone resistance determining 
regions of gyrA and gyrB subunits of DNA gyrase and parC and parE subunits of DNA 
topoisomerase IV are common.  These mutations reduce the binding affinity of the 
fluoroquinolone drug in those areas (8, 20).  Mutations in gyrA and gyrB tend to confer 
greater resistance in gram-negatives, as DNA gyrase is the primary target of the drug in 
those organisms.  In gram-positives, parC and parE mutations confer greater resistance 
(8).  Mutations in gyrA and parC are more common than in gyrB and parE (9).  Efflux 
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pumps are known to contribute to drug resistance and have been observed with 
fluoroquinolone-resistant bacteria. 
 The number and location of the mutations within the target cell’s DNA affects its 
resistance, though environmental conditions can influence resistance as well (22).  
Fluoroquinolone-resistant E. coli isolated from clinical and environmental sources gained 
resistance primarily through mutations in the target enzymes.  Clinical isolates had a 
higher prevalence of resistance and greater minimum inhibitory concentrations than did 
environmental isolates (23).  Multiple mutations tended to increase resistance and even 
confer multi-drug resistance.  For example, having mutations in both gyrA and efflux 
pump regions conferred greater resistance than did mutations in either region alone (23, 
24).  Studies of quinolone resistance in Campylobacter jejuni and C. coli noted that many 
of the mutations conferring resistance are similar in isolates obtained from both humans 
and chickens (24).  A study of quinolone-resistant clinical isolates of Staphylococcus 
aureus with multiple mutations encoding high levels of resistance maintained those 
resistance levels over a period of years, even in an antibiotic-free environment (20). 
Quinolone resistance conferred by plasmids has also been documented.  The main 
mechanisms include Qnr proteins, aminoglycoside acetyltransferase, and efflux pumps 
QepA and OqxAB (7).  Qnr proteins bind to the gyrA and gyrB subunits of DNA gyrase 
early in the gyrase catalytic cycle.  Later in the catalytic cycle, quinolones, if present, 
bind to the DNA molecule and gyrase, forming the drug-enzyme-DNA complex that 
disrupts DNA replication activity (25).  Qnr proteins reduce binding of DNA and gyrase, 
thereby reducing the potential DNA-enzyme complexes that are targeted by quinolones 
(26).  The plasmids that carry Qnr proteins often carry other antibiotic resistance genes 
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(27).  Plasmid-mediated Qnr genes have been found in E. coli isolates from many sources 
including cattle, poultry, and swine (28, 29).  A variant of the aminoglyoside 
acetyltransferase enzyme aac(6’)-lb, a known contributor to aminoglycoside resistance, 
has been shown to contribute to reduced susceptibility to ciprofloxacin as well. 
Modification of ciprofloxacin by the enzyme involves N-acetylation of the amino 
nitrogen on the drug’s piperazinyl substitutent, causing the reduction in drug activity 
(30).  The plasmid-mediated efflux pumps QepA and OqxAB increase resistance of the 
target cell because of improved drug efflux activity.  Plasmids can supply any of these 
mechanisms in an organism. 
 Overlap in bacterial resistance to drugs used to treat humans and those used to 
treat animals is of interest to researchers.  Isolates from animals or animal husbandry 
locations that are resistant to human antibiotics have been well documented.  For this 
reason, the European Union banned the use of the veterinary drug avoparcin, an analog of 
the human antibiotic vancomycin (31).  In Norway, vancomyin-resistant enterococci 
(VRE) have been isolated from fecal samples on poultry farms established both before 
and after the avoparcin ban.  However, the farms established before the ban had nearly 
six times the concentration of VRE as the study farms (32).  Enrofloxacin and 
danofloxacin are fluoroquinolones used to treat bacterial infections of the bovine 
respiratory and alimentary tracts.  Enrofloxacin is partially metabolized to ciprofloxacin 
in cattle.  In a study of calves, high concentrations of enrofloxacin, danofloxacin, and 
ciprofloxacin in the blood plasma, tissue cage exudate, and bronchial secretions were 
found.  Concentrations of the antibiotics were higher than the minimum inhibitory 
concentrations for some known bovine pathogens (33).  The U.S. Food and Drug 
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Administration banned the use of enrofloxacin to treat bacterial infections in poultry in 
July 2005 because of links to resistance in Campylobacter species (34).  Soil bacteria 
isolated from cattle holding pens at feedlots in Kansas documented resistance to 
ciprofloxacin, chloramphenicol, and tetracycline (35).  Fluoroquinolone resistance in 
humans tends to follow or coincide with approval of their use in animal husbandry (36). 
The objectives of this research were to describe the airborne dispersal of 
ciprofloxacin-resistant strains of bacteria from cattle feedlots in the central Great Plains 
region, to determine the abundances of ciprofloxacin-resistant bacteria that can be 
detected in the air at various distances downwind of these feedlots, and to identify 
environmental factors such as air temperature, wind speed, and relative humidity that 




MATERIALS AND METHODS 
Overview 
 I sampled airborne bacterial communities directly on, downwind of, and upwind 
of six feedlots in the central Great Plains region for resistance to ciprofloxacin.  At each 
location that a sample was taken, I measured environmental variables and distance from 
the feedlot.  The resulting bacterial growth indicated prevalence of antibiotic resistant 
bacteria around the feedlots.  I selected some resistant colonies, isolated them, stained 
them, and noted cell morphology.  I tested the isolates for ciprofloxacin minimum 
inhibitory concentrations and had 16S ribosomal subunit sequencing completed for 
identification of the isolates. 
 
Feedlot Sampling Design  
The air samples were taken on ciprofloxacin-infused agar.  I made a 1000x 
ciprofloxacin stock solution by dissolving 0.05g of ciprofloxacin powder in 10mL of 0.1 
molar NaOH.  I stored small aliquots of the stock solution in microcentrifuge tubes in a  
-20°C freezer.  These aliquots were thawed and used as needed.  I used Mueller-Hinton 
agar (MHA) for the growth media in standard, 100mm by 15mm Petri plate.  I diluted the 
1000x ciprofloxacin stock in the molten agar to achieve a working concentration of 
5µg/mL.  To suppress fungal growth, I added the antifungal amphotericin B (Fungizone) 
at a 250µg/mL concentration to the MHA plus ciprofloxacin plates for the first two 
sampling dates.  Some fungal growth on those samples made bacterial observation 
difficult, so I used the antifungal cycloheximide at a 0.15mg/mL final concentration in 
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the MHA plus ciprofloxacin plates for the last four sampling dates.  The cycloheximide 
better suppressed the growth of airborne fungal spores on the agar plates.  
To hold the uncovered MHA Petri plates in a vertical position during feedlot 
sampling, I used a wooden U-shaped frame.  The wooden frame sat atop an extended 
camera tripod at a height of two meters.  I positioned the tripod so that the uncovered 
plate faced into the wind.  I sampled the six central Great Plains feedlots six times in 
2013 (9 March, 4 May, 7 July, 18 August, 15 September, and 13 October).  For each 
feedlot, I collected six samples: one sample on the feedlot near the feeding pens, one 
sample about 1.5 kilometers upwind of the feedlot, three samples at distances downwind 
of the feedlot (roughly one kilometer, 1.6 kilometers and 3.2 kilometers away), and one 
sample 8 to 16 kilometers downwind of the feedlot (Fig 3).  The samples consisted of a 
MHA plus ciprofloxacin plate exposed for 10 minutes.  At each sample location, I noted 
the wind direction and environmental observations such as the type of surrounding 
vegetation or fallow fields, paved highway or dirt roads, or the presence of animals.  I 
used a Kestrel 3500NV pocket weather meter to measure wind speed, relative humidity, 
and temperature at every location from which a sample was taken.  I noted the 
coordinates of each location using a Garmin eTrex Legend GPS unit.  After returning to 
the lab, I used the GPS coordinates and ArcGIS (version 10) (37) to measure distances 
from each off-feedlot sample location to the feedlot. 
 
Lab Analysis of Bacterial Growth on Feedlot Samples  
All samples were incubated upon return to the lab.  I incubated all plates and 
broth cultures in this study at 37°C. This temperature is most relevant to the optimal 
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growth temperature of human pathogens.  I counted and recorded bacterial colonies on 
each plate at 24, 48, and 72 hours.  Among all of the sampling periods, I chose 60 of the 
larger bacterial colonies to isolate, as they presumably grew faster in the presence of 
ciprofloxacin than did smaller colonies.  Using the standard isolation streak plate 
protocol, I streaked out each of those colonies on MHA plus ciprofloxacin three 
consecutive times.  I gram-stained each isolate and viewed it at 1000x oil immersion with 
a compound light microscope.  I noted cell morphology, groupings, and the source of the 
isolate (Table 1).  If the isolates were not pure, I made additional isolation streak plates 
until they appeared pure on the gram-stain slide.  I then grew the isolates in Mueller-
Hinton broth (MHB) plus ciprofloxacin.  I stored a 750µl portion of each of the broth 
cultures with 250µl of 60% glycerol in 1.5-mL microcentrifuge tubes in a -80°C freezer. I 
periodically tested the agar, broth, antifungal and antibiotic using Escherichia coli 
(ATCC 25922) and Saccharomyces cerevisiae (ATCC 204508, S288C) to confirm their 
function. 
 
Ciprofloxacin Minimum Inhibitory Concentration Determination  
 For each isolate, I determined a minimum inhibitory concentration (MIC) of 
ciprofloxacin using Etest strips that had a 0.002µg/mL to 32µg/mL concentration 
gradient (bioMérieux, Durham, NC).  20µL portions of the broth cultures were grown in 
culture tubes using MHB without antibiotic until the broth appeared turbid (between 48-
72 hours).  I then transferred the MHB cultures to centrifuge tubes and centrifuged for 15 
minutes at 4000rpm.  I decanted the supernatant from each cell pellet.  Using 1-2mL of 
sterile 0.85% sodium chloride (NaCl) solution, I re-suspended each cell pellet in the 
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centrifuge tube, adding more of the NaCl solution as needed.  I used a Spectronic 
Genesys 5 spectrophotometer to standardize the NaCl-cell solution concentrations to the 
0.5 McFarland colorimeter standard recommended by bioMérieux.  Then I plated a lawn 
of the standardized NaCl-cell solutions with sterile swabs onto labeled MHA plates 
without antibiotic.  Using flame-sterilized forceps, I placed one ciprofloxacin Etest strip 
at the center of each of the inoculated MHA plates and then incubated the plates.  I 
checked the Etest plates after 16 and 24 hours of incubation, recording the ciprofloxacin 
MIC of each isolate by noting the position of the edge of the zone of inhibition on the 
labeled ciprofloxacin strip (Fig 4).  The sterility of the MHB and the 0.085% NaCl was 
tested and confirmed.  The Etest procedure was tested using E. coli (ATCC 25922) as a 
control before testing the bacterial isolates.  
 
Sequencing and Identification of Isolates  
 I made new isolation streak plates on MHA plus ciprofloxacin for 51 of the 60 
bacterial isolates; the other nine isolates did not appear pure after six consecutive 
isolation streak plates.  I shipped the streak plates to GeneWiz (South Plainfield, NJ) for 
16S ribosomal subunit sequencing.  No sequence data was obtained for 25 of the 51 
samples that failed PCR twice.  For the other 26 isolates, I imported the sequence files, 
both forward and reverse sequences, to the program CodonCode Aligner (version 4.2.4).  
First, I clipped the ends from each sequence.  After reviewing the accompanying trace 
data I replaced any ambiguous nucleotides in the sequences with the most likely 
nucleotide bases.  For five of the isolates, consensus sequences could not be assembled 
using the corrected forward and reverse sequences, so they were not included in the 
 
13 
analysis.  For the other 21 isolates, I assembled and exported the consensus sequences.  I 
uploaded the exported consensus sequences to the Basic Local Alignment Search Tool 
(BLAST) website maintained by the National Center for Biotechnology Information 
(NCBI).  The nucleotide BLAST algorithm compared the 16S ribosomal subunit 
consensus sequences to the collection of sequences in the National Institute of Health 
(NIH) database GenBank on 24 February 2014 to identify the most likely putative 
bacterial species for the 21 isolates.  The 16S sequences for the 21 isolates were 
submitted to GenBank on 21 April 2014.  
 
Statistical Analysis  
 I log-transformed the 72-hour bacterial colony counts (Table 2) from all 211 of 
the samples to obtain a normal distribution.  A scatterplot matrix of all the variables was 
constructed to identify confounding correlations between independent variables.  
Temperature and humidity appeared correlated, so only one of the variables would be 
used in the overall model.  Next, I removed statistical outliers using the aqplot procedure, 
which eliminated 34 samples.  I reconstructed the scatterplot matrix with the remaining 
177 samples to observe changes in the variable relationships.  A Shapiro-Wilk normality 
test of the 72-hour bacterial colony counts determined that the counts from the upwind, 
on the feedlot, and 8- to 16-kilometer locations were normally distributed and that the 
first, second, and third downwind distances were not normally distributed.  Normal 
quartile-quartile plots of the log-transformed 72-hour counts from the first, second, and 
third downwind distances each showed evidence of their slight departures from 
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normality.  The first downwind distance data were platykurtic, and the second and third 
downwind distance samples were right-skewed, but not enough to influence the model.   
After removing the upwind control values to ease the interpretation of the model, I 
performed a multiple regression to examine the log-transformed 72-hour bacterial counts 
from all of the other locations with temperature, relative humidity, wind speed, and 








Statistical Analysis of Bacterial Growth Near Feedlots  
Temperature did not contribute to the multiple regression model of all of the log-
transformed 72-hour colony counts with temperature, relative humidity, wind speed, and 
distance from the feedlot, so I removed it and repeated the procedure with the other three 
variables.  The second model of log-transformed 72-hour colony counts with relative 
humidity, wind speed, and distance from the feedlot was highly significant overall 
(R2=0.5723, F=67.01, df=3, 145, p<0.001), as were the contributions of each of the three 
variables (distance: t=-10.957, df=2, p<0.001; relative humidity: t=-7.027, df=2, p<0.001; 
wind speed: t=5.379, df=2, p<0.001), making it the best model (Table 3).  A global 
assessment of the second multiple regression model suggested the assumptions and fit of 
the model were appropriate.  I performed an analysis of covariance (ANCOVA) to 
compare the 72-hour colony counts on the six different classed samples (classes: U = 
upwind; 0 = on feedlot; 1, 2, 3, = first, second, and third downwind distances; and 10+ = 
8-16km downwind of feedlot) taken from each feedlot location.  The test detected the 
presence of a significant difference among the classes (F=15.3, df=5, p<0.001, Table 4), 
so I performed a Tukey’s multiple comparison of means to determine between which 
locations the difference occurred.  The Tukey’s test determined that the 72-hour colony 
counts from the feedlots were significantly greater than the counts from the off-the-
feedlot locations, but that none of the off-the-feedlot locations were significantly different 
from each other (Fig 5, Table 5).  I then performed an ANCOVA to compare the six 
feedlots by using log-transformed 72-hour counts by relative humidity, wind speed, and 
distance from the feedlot.  This ANCOVA model found that there was no significant 
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difference among the 72-hour bacterial colony counts of the different feedlots (F=28.04, 
df=8, 140, p<0.001, Table 6).    
 
Ciprofloxacin Minimum Inhibitory Concentration Determination 
Of the 21 bacterial isolates for which putative species identifications were 
determined, 18 isolates had ciprofloxacin MICs that were greater than 32µg/mL (Table 
7).  This suggested that they were uninhibited by the presence of the ciprofloxacin Etest 
strip.  The other three isolates had MICs of 20µg/mL, 12µg/mL, and 5µg/mL.  All 
isolated showed MICs equivalent to or greater than the working concentration of 5µg/mL 
and greater than the maximum serum concentrations of between 1 and 4µg/mL achieved 
from lower therapeutic doses. 
  
Sequencing and Identification of Isolates 
 Eight species were identified from the 21 bacterial isolates for which the 16S 
ribosomal RNA consensus sequences could be obtained (Table 8).  14 isolates 
represented four species of the genus Microbacterium, four isolates represented two 
species of the genus Arthrobacter, two isolates represented one species of the genus 
Enterococcus, and one isolate represented a species of the genus Cellulomonas.  For each 
isolate the query cover of the BLAST algorithm search, the percent of the query sequence 
that overlapped with the known subject sequence, was at least 98%, indicating a high 
degree of confidence in the species identifications.  The 21 sequenced bacterial isolates 
represented all six feedlots and a variety of distances ranging from 0.52 kilometers (3.22 





The prevalence of ciprofloxacin resistant bacteria detected near the central Great 
Plains feedlots was somewhat higher than expected.  The multiple regression intercept 
value of 5.2 indicated that five or more resistant colonies would be expected from any 
site at which a sample was collected (Table 3).  I expected the samples taken on the 
feedlots to have more antibiotic resistant bacteria than the other locations, but the lack of 
a difference between the non-feedlot locations was unanticipated.  Assuming the source 
of the antibiotic-resistant bacteria was indeed the feedlot, one might expect to see a 
decrease in prevalence of resistant bacteria with increasing distance from the feedlot.  It 
is possible that a negative exponential relationship existed between the number of 
antibiotic resistant bacterial colonies observed and distance from a feedlot, but the 
distances used in this study might have been too far from the feedlot to detect such a 
pattern.  The observed increase in bacterial prevalence with increased wind speeds could 
be attributed to greater amounts of particulate matter suspended with higher wind speeds.  
Conversely, I expected to see fewer colonies with higher relative humidity, as the 
increased moisture in the air, especially after a precipitation event, would likely settle any 
dust and topsoil particles.  
That the bacterial colony counts from the six feedlots did not significantly differ 
(Table 6) suggests that, at least for this study, factors such as the area of the feedlot or the 
number of cattle did not affect the number of resistant colonies I detected.  This study had 
high levels of variability, such as variation in the time of year or time of day the samples 
were collected, and different wind directions and weather conditions among the sampling 
dates, to name some.  Such variation could obscure existing patterns that this study did 
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not detect.  There was a large amount of variation in numbers of colonies observed 
among the distance classes as well, and this further complicates the detection of the 
relationship between distance from the feedlot and number of resistant colonies detected.   
Increasing the number of feedlots sampled, exposing multiple agar plates at each sample 
location, sampling at locations closer to the feedlots, and sampling each feedlot more 
frequently are all methods that might help clarify patterns of antibiotic-resistant bacterial 
dispersal from feedlots.  
 All of the isolates had ciprofloxacin MICs at least as high as the working 
concentration and in most cases greater than the 32 µg/mL concentration of the Etest 
strip.  This is noteworthy, considering that the isolates represented various distances away 
from all six of the feedlots studied (Table 7).  Many off-the-feedlot locations were by 
agricultural fields or near sparsely populated rural areas, areas where presumably no 
antibiotics are used.  Quinolone production by bacteria has not been observed (21).  
Therefore, it is unlikely that an unexposed organism could acquire resistance specific to 
quinolones because they are not known to occur naturally in the environment.  It is 
possible that the acquisition of a generic resistance mechanism, such as a plasmid-
mediated efflux pump, or exposure to a related molecule that might exist in the 
environment could encourage ciprofloxacin resistance without exposure to the drug.  This 
study suggested that the higher levels of ciprofloxacin resistance I observed on the 
feedlots than at the other locations might be due to the use of antibiotics at the feedlots 
(Fig 5).  
 The putative identifications of the 21 ciprofloxacin-resistant bacterial isolates 
sequenced represented eight species in four genera (Table 8).  The species identifications 
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were considered putative because although 16S ribosomal sequencing has gained 
popularity due to the relative ease of the technique, it does not have the same degree of 
discriminatory power at the species level as other sequencing methods, such as DNA-
DNA hybridization (38).  The five isolates for which consensus sequences could not be 
assembled either showed overlapping peaks on the traces, indicating nonhomogenous 
bacterial colonies, or they had very short forward and reverse segments for which 
CodonCode Aligner could not detect regions of overlap.  The species for which PCR was 
not completed represented all six feedlots and multiple distances from feedlots.  Reasons 
why PCR might have failed and no sequences were obtained could be inappropriate 
primers, suboptimal reaction conditions, too little or too much nucleic acid template, 
insufficient number of cycles or incorrect temperature settings on the thermal cycler (39), 
or degradation of or absence of the region where PCR primers bind to the template.  If the 
primer-binding region was lacking, it could indicate that the isolate was not a bacterial 
species, but perhaps a fungal species with cellular appearance similar to bacteria.  This is 
further supported by studies demonstrating that some fungal species are capable of 
ciprofloxacin degradation. (40, 41) 
Fourteen isolates were of the Microbacterium genus, with 12 representing two 
strains of M. testaceum.  Microbacterium testaceum is a gram-positive endophytic 
bacterium; it lives within a plant host (42).  Endophytic bacteria can reside within a 
variety of plant hosts, within different tissue types of those hosts (in vascular tissue, 
intracellular spaces, or within plant cells), and can have multiple points of entry into the 
plant host such as through roots zones, stems, or floral portions.  One plant might host a 
number of different endophytic species (43).  Microbacterium testaceum has been 
20 
 
isolated from many different agricultural plants, including rice, potatoes, corn, and 
sorghum, as well as some perennial prairie plants.  This species was found in isolates 
from all six feedlots and from multiple distances from feedlots, suggesting that it might 
be a common endophyte of one or many of the plants growing near these feedlots.  The 
other two species in this genus were M. hominis, short, irregular rods, and M. insulae, 
rods or cocci; both have previously been detected in soils (44).  
 Four isolates represented the gram-positive soil-dwelling genus Arthrobacter, 
with two each being identified as A. nicotinovorans and A. nitroguajacolicus.  
Arthrobacter nicotinovorans isolates have been observed to harbor a large conjugative 
catabolic plasmid that confers the ability to use alkaloid nicotine as a carbon and nitrogen 
source.  Portions of this plasmid are also known to be associated with multi-drug efflux 
pumps and drug resistance to vancomycin, ethidium bromide, and some heavy metals 
(45).  A rod-coccus life cycle where younger cells have a rod-shaped appearance and 
older cells have a cocci appearance has been observed in A. nitroguajcolicus.  This 
species is capable of degrading some nitroaromatic compounds and has also been isolated 
from forest soils (46). 
 One of the isolates represented Cellulomonas flavigena, a potentially quickly-
decolorizing gram-positive, rod-shaped or coryneform bacterium.  The fast decolorization 
of the cells during gram staining has been documented and could account for the feedlot 
isolate appearing gram-negative on the stain slide (47).  Cellulomonas flavigena has been 
isolated from activated sludge and from the rumen of animals that do ruminant digestion.  
Because one of its characteristics is the ability to degrade xylan, starch, and cellulose, C. 
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flavigena has been isolated from cellulose-rich environments like soil, sugarcane fields, 
bark, and other woody sources (48).  
 The last two isolates were both Enterococcus faecium, a member of the gram-
positive genus of common gastrointestinal cocci.  Enterococcus species are often 
commensal but can be pathogenic.  Vancomycin-resistant enterococci (VRE) are an 
example of runaway antibiotic resistance by a notable nosocomial pathogen that has 
caused trouble for patients and hospitals since the 1980s.  Distinct prophages, insertion 
sequence elements, and multiple copies of three different plasmids, have been noted in 
the vancomycin-resistant E. faecium strain Aus0004.  The plasmids carried regions 
suggestive of antimicrobial resistance and conjugation mechanisms (49).  Generally, two 
subpopulations of E. faecium are recognized, resistant pathogenic strains and benign 
strains that are susceptible to antibiotic treatment.  Benign strains have been used in feed 
additives as probiotics with mixed results (50).  The European Food Safety Authority has 
stated that strains of E. faecium with any of three genetic markers for resistance or 
resistance to ampicillin greater than 2mg/L should not be used as a feed additive (51).  
The study of antibiotic resistant soil bacteria from feedlots conducted by Zwenger, 
Welsch, and Gillock also found an Enterococcus isolate, E. hirae, that did not exhibit 
ciprofloxacin resistance but had strong resistance to tetracycline (35).   
All of the sequenced antibiotic-resistant bacterial isolates represented gram-
positive species.  The observed negative gram-stain results might be an error of the 
staining procedure.  Nineteen of the isolates represented common soil-dwelling genera.  
Soil is the source of many classes of antibiotics and a vast reservoir for antibiotic 
resistance genes (52).  While soil contains some of the greatest bacterial diversity (53), 
22 
 
only a small fraction of those organisms are culturable by current lab methods.  These 
results are comparable to a 2002 study of airborne microbial flora in a cattle feedlot from 
which only non-pathogenic gram-positive bacterial species were recovered (54).  The 
authors speculated that gram-negative bacteria might have been present in a viable but 
nonculturable state due to cell damage or to their susceptibility to environmental stressors 
like desiccation, UV radiation, and temperature fluctuations.  Those types of 
environmental stressors might explain the lack of greater species richness in this study.  
Using large colony size as the criterion for selecting colonies to isolate instead of other 
factors (color, location on the agar plate, morphology, etc.) might also account for the 
lack of greater observed species richness.   
The dispersal and ubiquity of bacteria has been studied, but the degree to which 
microorganisms adhere to biogeographic patterns observed in macroorganisms is still 
unclear (53).  Non-random distribution across landscapes and species-area relationships 
in contiguous and island habitats have been observed for microbial taxa.  However, few 
of these studies report geographic distances between samples or test for a distance effect, 
so it is difficult to draw conclusions from them (55).  Compared to macroorganisms, 
bacteria are limited in their active dispersal, but they are quite capable of passive 
dispersal.  Different species of bacteria have different tolerances to environmental 
conditions they might encounter during dispersal.  This suggests that some species 
disperse and survive better in new environments than others (55).  
While high variability might have obscured patterns of dispersal of antibiotic-
resistant bacteria, this study does clarify the picture of airborne resistance near feedlots in 
the central Great Plains.  The greater abundance of antibiotic-resistant bacteria on the 
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feedlots suggested that locations farther away are at a lower risk of exposure to airborne 
antibiotic-resistant bacteria.  Cattle feedlots have been associated with high dust 
production due to the lack of vegetation and the active behavior of the cattle disturbing 
the soil (53).  These ideas lend support to the greater frequency of resistant colonies 
detected on the feedlots than at other locations.  Without knowing the mechanisms of 
ciprofloxacin resistance in this study’s bacterial isolates, it is difficult to assess the risk of 
those mechanisms spreading to potential pathogenic species.  However, the spread of 
resistance has been studied for years, and its potential is something to consider, especially 
relative to the current rates of antibiotic drug use in humans and animals.  Unless drugs 
with new mechanisms of action can be developed, we can only hope to stay ahead of 
antibiotic resistant pathogens through modifications of current drugs (56).  More prudent 
and selective use of existing antibiotics, more accurate diagnostics, and better 
communication between medical experts and patients about appropriate drug use are the 
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TABLE 1.  Descriptors of the 21 bacterial isolates, including the feedlot source, the 
distance from the feedlot in miles and kilometers (negative values indicate upwind 
source, values of zero indicate the isolate was obtained directly from the feedlot) from 
which it was collected, the collection month, observed gram stain, observed cell 





(km) Month Gram stain Cell shape Cell grouping 
8  6 1.78 2.86 March positive rods (small) clusters 
16  2 -1.23 -1.98 May negative rods (small) 1s, clusters 
17  1 -3.22 -5.18 May positive rods clusters 
24  5 0.56 0.90 July positive cocci 2s, clusters 
27  2 1.16 1.87 July negative cocci clusters 
33  6 0 0 August negative coccobacilli clusters 
35  4 0.68 1.09 August negative rods (small) chains, clusters 
37  2 10.62 17.09 August negative rods clusters 
38  1 -2.02 -3.25 August positive rods 2s, clusters 
39  6 11.03 17.75 August positive rods 1s, 2s, clusters 
40  3 2.04 3.28 August positive rods (small) 1s, 2s, clusters 
44  2 1.17 1.88 September negative rods (small) clusters 
46  6 10.93 17.59 September positive rods chains, branching 
51  6 1.3 2.09 October positive rods 1s, clusters, chains 
54  1 1.09 1.75 October positive rods 2s, clusters, chains 
55  3 10.71 17.24 October positive rods 2s, clusters, chains 
56  3 0.68 1.09 October positive rods clusters 
57  3 0.68 1.09 October positive rods (long) chains, clusters 
58  4 1.15 1.85 October negative rods (small) chains, clusters 
59  4 1.15 1.85 October positive rods clusters 




TABLE 2.  Summary of samples, including feedlot (site), collection month, classed 
distance from feedlot (classes: U = upwind; 0 = on feedlot; 1, 2, 3, = first, second, third 
downwind distances; 10+ = 8-16km downwind of feedlot), air temperature, relative 
humidity, wind speed, 72-hour bacterial colony counts, and distance from the feedlot. 
Site Month Class Temp (˚C) Humidity WindSpd (km/h) B72hr Dist. (km) 
1 August 0 27.3 52.2 22.4 566 0 
1 August 1 27.8 54.8 23.7 138 3.58 
1 August 2 26.5 58.7 22.9 9 4.88 
1 August 3 27.0 55.1 18.2 0 6.56 
1 August 10+ 26.5 60.3 21.7 4 16.99 
1 August U 27.0 58.2 24.1 6 -3.22 
1 July 0 38.0 23.1 29.9 490 0 
1 July 1 37.5 21.2 35.1 460 3.58 
1 July 2 37.4 20.4 28.8 123 4.86 
1 July 3 37.3 22.3 30.3 109 6.55 
1 July 10+ 37.9 22.5 33.0 9 21.04 
1 July U 36.9 22.7 33.0 15 -3.22 
1 March 0 13.1 87.4 27.7 67 0 
1 March 1 13.0 91 22.2 4 0.75 
1 March 2 13.3 90.3 19.5 3 2.01 
1 March 3 13.4 56.2 141.8 0 3.69 
1 March 10+ 12.4 82.3 17.7 0 12.82 
1 March U 12.8 91.4 19.0 0 -5.3 
1 May 0 6.2 55.9 33.8 76 0 
1 May 1 8.1 43.5 37.5 160 0.81 
1 May 2 7.0 44.8 32.0 33 1.61 
1 May 3 7.1 50.1 39.4 99 3.22 
1 May 10+ 3.9 54.5 25.6 1 14.56 
1 May U 6.1 50.5 34.8 50 -5.19 
1 October 0 22.3 40.2 26.1 1342 0 
1 October 1 21.8 42.5 23.3 15 1.76 
1 October 2 21.6 43.4 29.8 15 2.6 
1 October 3 20.8 47.6 25.6 20 4.75 
1 October 10+ 20.4 49.2 36.0 40 19.85 
1 October U 21.8 38.5 24.5 15 -3.23 
1 September 0 27.7 60.3 37.3 4800 0 
1 September 1 28.0 59.2 28.2 174 1.38 
1 September 2 28.5 58.3 35.1 184 1.65 
1 September 3 28.9 54.4 24.8 92 3.25 
1 September 10+ 24.4 65.5 37.5 31 20.06 
34 
 
1 September U 25.7 66 28.2 151 -5.06 
2 August 0 26.3 54.6 26.1 630 0 
2 August 1 26.8 57.6 24.6 9 1.12 
2 August 2 27.2 55.8 34.0 3 2.21 
2 August 3 27.0 53.1 21.2 11 5.09 
2 August 10+ 25.4 65.9 19.5 5 17.1 
2 August U 27.3 56 22.9 5 -1.8 
2 July 2 38.3 22.2 36.4 17 1.87 
2 July 3 38.5 22.4 41.8 35 3.47 
2 July 10+ 36.7 25.8 21.4 10 17.09 
2 July U 36.6 27.3 26.4 14 -1.8 
2 March 0 12.9 88.8 24.0 4 0 
2 March 1 12.8 90.1 28.5 1 1.11 
2 March 2 13.5 87.5 25.7 1 1.88 
2 March 3 14.1 87.2 30.6 0 3.48 
2 March 10+ 13.1 88.7 26.4 1 14.83 
2 March U 13.6 90.7 34.1 5 -1.8 
2 May 1 10.7 40.5 36.2 95 1.27 
2 May 2 11.6 39.3 42.6 61 2.09 
2 May 3 11.8 39.5 33.6 90 3.69 
2 May 10+ 9.1 40.2 41.2 31 19.64 
2 May U 10.1 39.5 36.7 90 -1.98 
2 October 0 22.3 38 27.8 1860 0 
2 October 1 21.2 40.3 30.3 7 1.95 
2 October 2 22.8 38.6 25.3 12 2.85 
2 October 3 22.1 36.7 31.2 10 4.26 
2 October 10+ 20.9 36.6 22.7 112 17.21 
2 October U 22.1 40.7 29.3 408 -1.73 
2 September 0 33.9 34.7 12.2 155 0 
2 September 1 38.7 36.6 15.6 172 1.12 
2 September 2 34.8 33.5 28.8 14 1.88 
2 September 3 30.0 49.9 24.8 1 3.49 
2 September 10+ 32.9 36.8 14.6 1 17.11 
2 September U 32.3 34.5 11.4 1 -1.79 
3 August 0 24.9 60.6 23.8 507 0 
3 August 1 24.0 65.8 21.6 2 0.084 
3 August 2 25.1 62.6 18.8 3 1.69 
3 August 3 23.2 64.4 19.5 5 3.28 
3 August 10+ 26.3 62.2 22.5 0 17.47 
3 August U 25.2 61.3 16.4 0 -1.56 
3 July 0 34.0 33.4 28.2 810 0 
3 July 1 36.6 27.5 25.7 180 0.9 
3 July 3 36.3 33 21.7 83 3.27 
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3 July 10+ 31.3 42 21.6 17 17.36 
3 July U 34.5 32.3 22.5 12 -1.74 
3 March 0 15.4 84.1 34.0 18 0 
3 March 1 16.8 76.9 32.7 1 0.76 
3 March 2 16.8 76 38.3 1 1.57 
3 March 3 18.8 66.2 38.5 1 3.21 
3 March 10+ 15.4 83.3 35.1 10 15.65 
3 March U 16.2 82.4 34.8 4 -1.81 
3 May 0 11.2 50.5 32.7 263 0 
3 May 1 10.5 57.3 28.5 20 1.2 
3 May 2 11.3 50.8 31.4 163 1.91 
3 May 3 10.3 52.6 46.7 53 3.04 
3 May 10+ 10.9 45.5 29.0 134 19.7 
3 May U 10.3 59.8 27.8 8 -2.03 
3 October 0 21.6 31.1 27.2 1810 0 
3 October 1 20.7 35.8 28.6 203 1.09 
3 October 2 20.5 31.1 21.4 147 2.12 
3 October 3 19.1 30.4 22.9 24 0.37 
3 October 10+ 20.1 37.3 20.4 12 17.23 
3 October U 21.8 33.1 28.0 21 -2.32 
3 September 0 31.0 46.9 12.2 758 0 
3 September 1 31.3 45.1 10.1 1 1 
3 September 2 30.7 44.3 6.6 0 1.88 
3 September 3 30.3 44.9 13.7 4 3.52 
3 September 10+ 31.6 46.2 8.9 6 17.57 
3 September U 31.7 45.4 17.9 2 -1.88 
4 August 0 21.4 67.3 19.8 217 0 
4 August 1 23.2 65.5 16.3 22 1.1 
4 August 2 22.4 68.8 18.0 0 1.85 
4 August 3 22.7 67.4 22.4 2 3.34 
4 August 10+ 20.2 72.7 22.4 0 22.68 
4 August U 22.3 70.5 18.8 0 -1.63 
4 July 0 29.2 47.4 28.2 1300 0 
4 July 1 29.4 45.2 24.1 810 1.1 
4 July 2 29.8 45.4 32.3 588 1.83 
4 July 3 31.1 38.9 34.8 5 3.33 
4 July 10+ 26.9 53.7 23.2 10 19.52 
4 July U 31.2 37.6 30.9 66 -1.63 
4 March 0 18.8 71.8 17.2 4 0 
4 March 1 16.0 82.3 32.5 1 1.08 
4 March 2 15.8 81.8 30.1 1 1.78 
4 March 3 14.1 82.4 25.1 0 3.36 
4 March 10+ 17.3 76.2 37.8 7 14.74 
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4 March U 16.0 84.4 33.6 2 -1.58 
4 May 0 9.2 61.6 24.1 118 0 
4 May 1 9.2 63.1 33.6 13 1.46 
4 May 2 9.7 64.1 42.0 15 2.33 
4 May 3 9.2 62.7 30.6 3 3.9 
4 May 10+ 9.8 53.8 35.1 1 30.44 
4 May U 9.2 59.7 29.5 50 -1.86 
4 October 0 16.2 40.6 23.8 5100 0 
4 October 1 17.3 34 26.7 770 0.91 
4 October 2 19.2 34.4 33.0 44 1.86 
4 October 3 19.5 31.1 30.4 197 3.6 
4 October 10+ 14.3 44.4 25.9 3 22.47 
4 October U 17.1 34.2 24.9 12 -1.73 
4 September 0 25.7 61.6 23.0 1900 0 
4 September 1 27.4 55.9 20.6 71 1.09 
4 September 2 26.6 56.4 9.7 1 1.81 
4 September 3 26.3 55.4 16.1 3 3.32 
4 September 10+ 24.6 62.7 15.6 2 22.63 
4 September U 26.7 55.5 13.7 9 -1.71 
5 August 0 18.1 81.3 12.4 34 0 
5 August 1 17.8 82.3 11.3 0 0.91 
5 August 2 17.5 85.7 8.7 0 1.71 
5 August 3 18.1 77.7 4.3 0 3.28 
5 August 10+ 19.9 79.5 15.4 0 17.46 
5 August U 18.2 83.8 12.2 0 -1.65 
5 July 1 24.5 60 15.8 153 0.89 
5 July 2 24.2 60.4 21.2 17 1.95 
5 July 3 23.8 61.1 21.7 2 3.27 
5 July 10+ 25.8 54.1 22.7 4 17.46 
5 July U 24.9 57.9 25.6 3 -1.65 
5 March 0 16.0 51.4 15.9 42 0 
5 March 1 15.4 54.2 20.6 1 0.98 
5 March 2 12.6 64 28.3 8 1.97 
5 March 3 10.1 66.2 24.0 15 3.85 
5 March 10+ 18.0 56.9 27.8 5 14.04 
5 March U 16.9 41.9 21.1 1 -1.69 
5 May 0 9.8 58.4 24.1 7 0 
5 May 1 9.2 64.6 20.0 2 0.87 
5 May 2 9.3 59 30.4 1 1.69 
5 May 3 9.6 53.7 22.7 3 3.5 
5 May 10+ 8.7 67.4 26.2 2 16.67 
5 May U 9.2 63.5 30.6 5 -1.97 
5 October 0 6.8 71.7 1.4 0 0 
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5 October 1 10.1 58.4 1.8 0 0.94 
5 October 2 5.8 85.4 4.0 1 1.83 
5 October 3 10.3 50.6 1.8 1 3.73 
5 October 10+ 13.0 70.6 6.4 0 17.55 
5 October U 3.5 89.2 2.1 0 -1.74 
5 September 0 20.6 79.2 12.2 55 0 
5 September 1 20.1 81.2 12.1 0 0.94 
5 September 2 19.9 80.6 11.1 1 1.73 
5 September 3 19.8 79.7 6.8 0 3.3 
5 September 10+ 23.6 66.4 19.0 2 17.54 
5 September U 20.8 77.1 10.6 1 -1.66 
6 August 0 25.8 58.5 22.2 16 0 
6 August 1 25.2 60.6 16.9 1 1.02 
6 August 2 24.6 63.8 18.8 1 1.87 
6 August 3 23.8 66.9 12.6 0 3.44 
6 August 10+ 26.0 59.2 22.7 2 17.75 
6 August U 26.0 58.7 20.8 150 -1.9 
6 July 0 27.7 57.9 11.6 3 0 
6 July 1 29.0 53.3 11.4 1 1.08 
6 July 2 30.4 39.3 22.9 2 1.71 
6 July 3 31.3 38.7 34.8 19 3.39 
6 July 10+ 35.2 23.7 24.0 7 17.76 
6 July U 29.5 45.4 11.1 2 -1.89 
6 March 0 2.5 77.3 33.6 59 0 
6 March 1 2.4 77.5 30.9 0 0.83 
6 March 2 2.4 75.3 20.1 2 1.69 
6 March 3 2.7 76 20.1 5 2.87 
6 March 10+ 2.7 89.5 28.8 7 8.22 
6 March U 2.7 74.5 32.0 4 -1.6 
6 May 0 11.2 54.9 20.0 100 0 
6 May 1 9.5 58.7 23.3 2 0.94 
6 May 2 12.7 51.9 24.5 4 1.7 
6 May 3 12.1 50.2 18.8 0 2.95 
6 May 10+ 14.2 49.7 26.6 7 17.55 
6 May U 8.9 62.1 20.8 7 -1.61 
6 October 0 18.3 58 15.0 820 0 
6 October 1 18.1 57.5 18.2 12 1.07 
6 October 2 17.6 61.6 17.5 20 2.1 
6 October 3 16.6 65.5 20.4 2 4.06 
6 October 10+ 18.9 54.3 28.8 1 17.65 
6 October U 18.6 57.2 17.7 1 -1.98 
6 September 0 17.6 85.6 30.7 1245 0 
6 September 1 17.6 86.2 27.0 1 0.74 
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6 September 2 18.6 82 21.7 3 1.69 
6 September 3 19.1 79.1 21.7 3 2.95 
6 September 10+ 19.3 79.3 31.1 63 17.59 
6 September U 17.8 84.2 23.5 41 -1.9 I I I I I I I I 
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TABLE 3.  Details of the multiple regression model overall and of specific variables 
which had a significant effect on bacterial growth. 





Overall model 67.01 3, 145 0.5723 <0.001 
          
Factor Coefficient Std. Error t-value P 
Distance -0.37987 0.003467 -10.957 <0.001 
Humidity -2.62923 0.37414 -7.027 <0.001 
Wind Speed 1.39044 0.25848 5.379 <0.001 




TABLE 4.  Details of the analysis of covariance (ANCOVA) used to detect significant 
differences in 72-hour bacterial colony counts among the six classes of sample distances 
per feedlot (classes: U = upwind; 0 = on feedlot; 1, 2, 3, = first, second, third downwind 
distances; 10+ = 8-16km downwind of feedlot). 
 
Deg. 
Freedom Sum Sq. Mean Sq. F value Pr(>F) 
Class Code 5 45.97 9.193 15.3 2.02E-12 




TABLE 5.  Details of the Tukey’s multiple comparison of means test (with a 95% 
family-wise confidence level) that compared pair-wise the average number of 72-hour 
bacterial colony counts from each of the six classes of sample distances per feedlot 
(classes: U = upwind; 0 = on feedlot; 1, 2, 3, = first, second, third downwind distances; 
10+ = 8-16km downwind of feedlot). 
Comparison diff p adj 
0--U 1.40945359 0.0000000 
1--U 0.27339817 0.7548713 
2--U 0.10940456 0.9941608 
3--U 0.05500589 0.9998028 
10+--U 0.15565493 0.9800946 
1--0 -1.13605543 0.0000003 
2--0 -1.30004903 0.0000000 
3--0 -1.35444770 0.0000000 
10+--0 -1.25379867 0.0000002 
2--1 -0.16399360 0.9596683 
3--1 -0.21839227 0.8807614 
10+--1 -0.11774324 0.9938274 
3--2 -0.05439867 0.9997799 
10+--2 0.04620360 0.9999310 




TABLE 6.  Details of the analysis of covariance (ANCOVA) used to detect significant 
differences in 72-hour bacterial colony counts among the six feedlots. 
Coefficients Estimate Std. Error t value Pr(>|t|) 
(Intercept) 5.40095 0.78159 6.910 1.57e-10 
LogHumidity -2.60441 0.39033 -6.672 5.41e-10 
LogWindSpd 1.21127 0.28331 4.275 3.51e-05 
LogDistance -0.36696 0.03408 -10.767 < 2e-16 
Site 2 -0.20661 0.17642 -1.171 0.244 
Site 5 -0.11085 0.19020 -0.583 0.561 
Site 4 0.15267 0.17382 0.878 0.381 
Site 6 -0.24116 0.16983 -1.420 0.158 
Site 1 0.27199 0.18304 1.486 0.140 
          
Residual standard error: 0.6106 on 140 deg. freedom 
Multiple R-squared: 0.618, Adjusted R-squared: 0.5938 




TABLE 7.  Minimum inhibitory concentrations (MIC) as determined by Etest 








8 6 1.78 2.86 March >32 
16 2 -1.23 -1.98 May >32 
17 1 -3.22 -5.18 May >32 
24 5 0.56 0.90 July >32 
27 2 1.16 1.87 July >32 
33 6 0 0 August >32 
35 4 0.68 1.09 August >32 
37 2 10.62 17.09 August >32 
38 1 -2.02 -3.25 August >32 
39 6 11.03 17.75 August >32 
40 3 2.04 3.28 August >32 
44 2 1.17 1.88 September >32 
46 6 10.93 17.59 September 5 
51 6 1.3 2.09 October >32 
54 1 1.09 1.75 October >32 
55 3 10.71 17.24 October >32 
56 3 0.68 1.09 October >32 
57 3 0.68 1.09 October >32 
58 4 1.15 1.85 October 12 
59 4 1.15 1.85 October 20 




TABLE 8.  The putative identification of the 21 isolates using 16S ribosomal subunit 
sequencing, including the feedlot source of the isolate, the distance in miles and 
kilometers from the feedlot (negative values indicate upwind source, values of zero 
indicate the isolate was obtained directly from the feedlot) from which it was obtained, 
and the month it was collected.  The max and total scores, query cover, and accession 
numbers are from the BLAST search results, and all isolates had E values of 0 (indicating 
highly significant matches) and Ident values of 99% (the percent similarity between the 













8 6 1.78 2.86 March Microbacterium testaceum StLB037 2512 2512 100% NR_074641.1 
16 2 -1.23 -1.98 May Microbacterium testaceum StLB037 2523 2523 100% NR_074641.1 
17 1 -3.22 -5.18 May Microbacterium testaceum DSM 20166 2490 2490 100% NR_026163.1 
24 5 0.56 0.90 July Enterococcus faecium Aus0004 2508 2508 99% NR_102790.1 
27 2 1.16 1.87 July Enterococcus faecium Aus0004 1382 1382 100% NR_102790.1 
33 6 0 0 August Microbacterium testaceum DSM 20166 2473 2473 100% NR_026163.1 
35 4 0.68 1.09 August Cellulomonas flavigena DSM 20109 2422 2422 98% NR_074490.1 
37 2 10.62 17.09 August Microbacterium testaceum DSM 20166 2529 2529 100% NR_026163.1 
38 1 -2.02 -3.25 August Microbacterium testaceum StLB037 2536 2536 100% NR_074641.1 
39 6 11.03 17.75 August Microbacterium testaceum DSM 20166 2473 2473 100% NR_026163.1 
40 3 2.04 3.28 August Microbacterium testaceum DSM 20166 2488 2488 100% NR_026163.1 
44 2 1.17 1.88 September Microbacterium insulae DS-66 2433 2433 100% NR_044440.1 
46 6 10.93 17.59 September Arthrobacter nitroguajacolicus G2-1 2525 2525 100% NR_027199.1 
51 6 1.3 2.09 October Microbacterium testaceum DSM 20166 2490 2490 100% NR_026163.1 
54 1 1.09 1.75 October Microbacterium testaceum DSM 20166 2486 2486 100% NR_026163.1 
55 3 10.71 17.24 October Microbacterium hominis DSM 12509 2398 2398 100% NR_042480.1 
56 3 0.68 1.09 October Microbacterium testaceum DSM 20166 2505 2505 100% NR_026163.1 
57 3 0.68 1.09 October Arthrobacter nicotinovorans DSM 420 2235 2235 100% NR_026194.1 
58 4 1.15 1.85 October Arthrobacter nicotinovorans DSM 420 2386 2386 100% NR_026194.1 
59 4 1.15 1.85 October Arthrobacter nitroguajacolicus G2-1 2499 2499 100% NR_027199.1 






FIG 1.  The structures of the 4-quinolone nucleus with labeled carbon atoms, the first-
generation quinolones nalidixic acid and oxolinic acid, and six later-generation 
fluoroquinolones and their common and unique substituents. (Adapted from 5) 
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FIG 2.  Chemical structures of common later-generation fluoroquinolones. (Adapted 
from 27) 
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FIG 3.  This map is a sample schematic representation of the possible dispersal of 
antibiotic-resistant bacteria.  This sample feedlot is outlined in orange, the hypothetical 
wind direction is indicated by the white arrow, and the overlapping red ellipses represent 






FIG 4.  An example of a ciprofloxacin minimum inhibitory concentration (MIC) 






FIG 5.  Ciprofloxacin-resistant bacterial colony growth results with 95% confidence 
limits after 72 hours of 37°C incubation of all air samples from the six central Great 
Plains feedlots with outliers removed.  Columns labeled A were not significantly 




APPENDIX A.  GenBank accession numbers for the 16S ribosomal RNA subunit 
sequences of the 21 ciprofloxacin-resistant bacterial isolates. 
Isolate Accession Number 
8 KJ726687 
16 KJ726688 
17 KJ726668 
24 KJ726669 
27 KJ726670 
33 KJ726671 
35 KJ726672 
37 KJ726673 
38 KJ726674 
39 KJ726675 
40 KJ726676 
44 KJ726677 
46 KJ726678 
51 KJ726679 
54 KJ726680 
55 KJ726681 
56 KJ726682 
57 KJ726683 
58 KJ726684 
59 KJ726685 
60 KJ726686 
 
